’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease..., with a solid focus on quality and accuracy. What you can expect of us As we work to develop treatments that deal...
Expert view: Amit Premchandani, Senior Vice President and Fund Manager – Equity at UTI AMC, says disruption risks are emerging in stable sectors like consumer staples as new e-commerce brands challenge established players. Continue Reading »